These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602 [TBL] [Abstract][Full Text] [Related]
4. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B. Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181 [TBL] [Abstract][Full Text] [Related]
5. [Treatment outcome in primary testicular non-Hodgkin lymphoma]. Iványi JL; Marton E; Plander M; Engert ZV; Tóth C Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219 [TBL] [Abstract][Full Text] [Related]
6. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058 [TBL] [Abstract][Full Text] [Related]
7. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. O'Reilly SE; Connors JM; Howdle S; Hoskins P; Klasa R; Klimo P; Stuart DS J Clin Oncol; 1993 Nov; 11(11):2250-7. PubMed ID: 8229141 [TBL] [Abstract][Full Text] [Related]
8. Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse. Hoskins PJ; Le N; Gascoyne RD; Klasa R; Shenkier T; O'Reilly S; Connors JM Ann Oncol; 1997 Nov; 8(11):1125-32. PubMed ID: 9426332 [TBL] [Abstract][Full Text] [Related]
9. Single-center experience in the treatment of primary testicular lymphoma. Mihaljevic B; Vukovic V; Smiljanic M; Milic N; Todorovic M; Bila J; Andjelic B; Djurasinovic V; Jelicic J; Antic D Oncol Res Treat; 2014; 37(5):239-42. PubMed ID: 24853782 [TBL] [Abstract][Full Text] [Related]
10. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma. O'Reilly SE; Klimo P; Connors JM J Clin Oncol; 1991 May; 9(5):741-7. PubMed ID: 1707954 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
12. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma. Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207 [TBL] [Abstract][Full Text] [Related]
13. [Seven patients with stage I and II primary testicular lymphoma]. Kondo T; Wada H; Yata K; Mikami M; Tsujioka T; Suemori S; Suetsugu Y; Nakanishi H; Otsuki T; Yamada O; Yawata Y; Morioka M; Tanaka H; Sadahira Y; Sugihara T Rinsho Ketsueki; 2002 Jun; 43(6):473-6. PubMed ID: 12134704 [TBL] [Abstract][Full Text] [Related]
14. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
15. MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study. Vitolo U; Bertini M; Brusamolino E; Cavallero GB; Comotti B; Gallo E; Ghio R; Levis A; Luxi G; Meneghini V J Clin Oncol; 1992 Feb; 10(2):219-27. PubMed ID: 1370690 [TBL] [Abstract][Full Text] [Related]
16. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. Linassier C; Desablens B; Lefrancq T; Le Prise PY; Harousseau JL; Jacob C; Gandhour C; Haillot O; Lucas V; Leloup R; Escoffre M; Colombat P; Tabuteau S; Clin Lymphoma; 2002 Dec; 3(3):167-72. PubMed ID: 12521394 [TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]